<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="Activity\PMC7582944\results\search\disease\results.xml">
  <result pre="neutrophils. Moreover, the extracts showed anti-allergic and cytotoxic effects against" exact="cancer" post="cells. Anti-coronavirus 229E and lipid formation activities were also"/>
  <result pre="several acute and chronic diseases, including lung injury, sepsis, or" exact="arthritis" post="[4]. We evaluated the effects of Iris extracts on"/>
  <result pre="all samples were evaluated for toxicity against RBL-2H3 (rat basophilic" exact="leukemia" post="cells) using MTT viability assay. The samples were found"/>
  <result pre="melanoma (IGR39) (IC50 0.53 and 1.15 mg/mL, respectively) and triple-negative" exact="breast cancer" post="(MDA-MB-231) (IC50 0.33 and 0.57 mg/mL, respectively) cell lines"/>
  <result pre="(IGR39) (IC50 0.53 and 1.15 mg/mL, respectively) and triple-negative breast" exact="cancer" post="(MDA-MB-231) (IC50 0.33 and 0.57 mg/mL, respectively) cell lines"/>
  <result pre="methanolic extract of I. kashmiriana rhizomes from Kashmir against epithelial" exact="cancer" post="cell lines including lung cancer A549 (IC50 0.13 mg/mL)"/>
  <result pre="kashmiriana rhizomes from Kashmir against epithelial cancer cell lines including" exact="lung cancer" post="A549 (IC50 0.13 mg/mL) and colon cancer Caco-2: (IC50"/>
  <result pre="rhizomes from Kashmir against epithelial cancer cell lines including lung" exact="cancer" post="A549 (IC50 0.13 mg/mL) and colon cancer Caco-2: (IC50"/>
  <result pre="cell lines including lung cancer A549 (IC50 0.13 mg/mL) and" exact="colon cancer" post="Caco-2: (IC50 0.24 mg/mL) [70]. All extracts demonstrated lower"/>
  <result pre="lines including lung cancer A549 (IC50 0.13 mg/mL) and colon" exact="cancer" post="Caco-2: (IC50 0.24 mg/mL) [70]. All extracts demonstrated lower"/>
  <result pre="[70]. All extracts demonstrated lower activity against melanoma cells. Triple-negative" exact="breast cancer" post="cells were 1.5â€&quot;2 times more sensitive. It is a"/>
  <result pre="All extracts demonstrated lower activity against melanoma cells. Triple-negative breast" exact="cancer" post="cells were 1.5â€&quot;2 times more sensitive. It is a"/>
  <result pre="usually characterized by a more aggressive nature compared with other" exact="cancer" post="cell lines [71]. Comparing the cytotoxic effect of the"/>
  <result pre="extract was more effective against both melanoma (IGR39) and triple-negative" exact="breast cancer" post="(MDA-MB-231) cells. 2.5.6. Lipid Formation Activity Non-alcoholic fatty liver"/>
  <result pre="was more effective against both melanoma (IGR39) and triple-negative breast" exact="cancer" post="(MDA-MB-231) cells. 2.5.6. Lipid Formation Activity Non-alcoholic fatty liver"/>
  <result pre="triple-negative breast cancer (MDA-MB-231) cells. 2.5.6. Lipid Formation Activity Non-alcoholic" exact="fatty liver disease" post="is a common liver disease caused mainly by obesity"/>
  <result pre="breast cancer (MDA-MB-231) cells. 2.5.6. Lipid Formation Activity Non-alcoholic fatty" exact="liver disease" post="is a common liver disease caused mainly by obesity"/>
  <result pre="Lipid Formation Activity Non-alcoholic fatty liver disease is a common" exact="liver disease" post="caused mainly by obesity and metabolic syndrome [72]. Lipid"/>
  <result pre="liver disease is a common liver disease caused mainly by" exact="obesity" post="and metabolic syndrome [72]. Lipid droplets are intracellular fat"/>
  <result pre="is a common liver disease caused mainly by obesity and" exact="metabolic syndrome" post="[72]. Lipid droplets are intracellular fat storage organelles found"/>
  <result pre="steatohepatitis (fatty liver), obesity, type 2 diabetes, and even facilitates" exact="hepatitis" post="type C virus infection [73]. Lipid droplets formation plays"/>
  <result pre="NRF2 nuclear factor erythroid 2-related factor 2 RBL rat basophilic" exact="leukemia" post="UPLC-MS/MS ultra-performance liquid chromatography coupled with tandem mass spectrometry"/>
  <result pre="related antioxidant compoundsAntioxidants2019835310.3390/antiox8090353 4.YangS.C.ChenP.J.ChangS.H.WengY.T.ChangF.R.ChangK.Y.ChenC.Y.KaoT.I.HwangT.L.Luteolin attenuates neutrophilic oxidative stress and inflammatory" exact="arthritis" post="by inhibiting RAF1 activityBiochem. Pharmacol.201815438439610.1016/j.bcp.2018.06.00329883707 5.NguyenT.H.LeH.D.KimT.N.T.TheH.P.NguyenT.M.CornetV.LambertJ.KestemontP.Anti-inflammatory and antioxidant properties"/>
  <result pre="parts of Iris nigricansEur. Sci. J.20139213218 33.ConfortiF.MenichiniF.RiganoD.SenatoreF.Antiproliferative activity on human" exact="cancer" post="cell lines after treatment with polyphenolic compounds isolated from"/>
  <result pre="from MoroccoPhytochem. Anal.20122345045510.1002/pca.137922213588 56.ZhengM.S.LuZ.Y.Antiviral effect of mangiferin and isomangiferin on" exact="herpes simplex" post="virusChin. Med. J.19901031601652167819 57.RajendranP.JayakumarT.NishigakiI.EkambaramG.NishigakiY.VetriselviJ.SakthisekaranD.Immunomodulatory effect of mangiferin in experimental"/>
  <result pre="71.LeeK.L.KuoY.C.HoY.S.HuangY.H.Triple-negative breast cancer: Current understanding and future therapeutic breakthrough targeting" exact="cancer" post="stemnessCancers201911133410.3390/cancers11091334 72.YenC.H.ChangH.S.YangT.H.WangS.F.WuH.C.ChenY.C.LinK.J.WangS.High-content screening of a taiwanese indigenous plant extract"/>
  <result pre="Res.20163053654310.1080/14786419.2015.102770325835071 78.ChenY.S.LaiC.C.KuoY.P.ChangH.S.ChenI.S.YenC.H.Identification of compound isolated from Beilschmiedia tsangii as a" exact="liver cancer" post="specific NRF2 inhibitor. In: Proceedings of the American Association"/>
  <result pre="78.ChenY.S.LaiC.C.KuoY.P.ChangH.S.ChenI.S.YenC.H.Identification of compound isolated from Beilschmiedia tsangii as a liver" exact="cancer" post="specific NRF2 inhibitor. In: Proceedings of the American Association"/>
  <result pre="Res.1992161165117310.1016/0145-2126(92)90114-M1361210 80.KorinekM.ChenK.M.JiangY.H.El-ShazlyM.StockerJ.ChouC.K.HwangT.L.WuY.C.ChenB.H.ChangF.R.Anti-allergic potential of Typhonium blumei: Inhibition of degranulation via" exact="suppression" post="of PI3K/PLCÎ³2 phosphorylation and calcium influxPhytomedicine2016231706171510.1016/j.phymed.2016.10.01127912872 81.ChenB.H.WuP.Y.ChenK.M.FuT.F.WangH.M.ChenC.Y.Antiallergic potential on"/>
  <result pre="NSAIDs activity in COX-2 expressing and non-expressing 2D and 3D" exact="pancreatic cancer" post="cell culturesCancer Manag. Res.2018101543155110.2147/CMAR.S16374729942156 88.HsiehC.F.JhengJ.R.LinG.H.ChenY.L.HoJ.Y.LiuC.J.HsuK.Y.ChenY.S.ChanY.F.YuH.M.et al.Rosmarinic acid exhibits broad"/>
  <result pre="activity in COX-2 expressing and non-expressing 2D and 3D pancreatic" exact="cancer" post="cell culturesCancer Manag. Res.2018101543155110.2147/CMAR.S16374729942156 88.HsiehC.F.JhengJ.R.LinG.H.ChenY.L.HoJ.Y.LiuC.J.HsuK.Y.ChenY.S.ChanY.F.YuH.M.et al.Rosmarinic acid exhibits broad"/>
  <result pre="effect of the tested extracts against melanoma (IGR39) and triple-negative" exact="breast cancer" post="(MDA-MB-231) cell lines. I. variegata rhizomes water extract, I."/>
  <result pre="of the tested extracts against melanoma (IGR39) and triple-negative breast" exact="cancer" post="(MDA-MB-231) cell lines. I. variegata rhizomes water extract, I."/>
 </snippets>
</snippetsTree>
